New therapeutic druge to fight ebola in DRC

Added On October 7, 2018

In the Democratic Republic of the Congo (DRC), five new therapeutics against Ebola have been approved for use. Patients can now receive them within hours of Ebola confirmation.
For the first time in the Democratic Republic of the Congo, new therapeutic drugs are part of the Ebola response. Five investigational therapeutics have been approved for use, and four have been used so far.
As of October 1st, 47 patients had been provided with the therapeutics. 
SOUNDBITE(French): RICHARD KOJAN, Alliance for International Medical Action
"In particular, I am happy that the therapeutics are finally available for the Congolese people, even for those living far away from the capital."
Clinicians from the World Health Organization (WHO) are involved in helping determine best treatment depending on clinical criteria, complexity of administration and monitoring capacities.
SOUNDBITE(English): WILLIAN?FISCHER, Case Management Coordinator, WHO
"I would say that there is a mix of emotions when you go into the Ebola treatment unit and deliver one of these therapeutics. On one hand, you are incredibly nervous because not many people were given these drugs before and not many people have received them. But on the other hand, there is a sense of excitement and hope because for the first time we have something to use to directly fight against the virus."
The Ebola virus'?fatality rate for humans is around 50 percent. The world's population is now highly mobile and the threat of infectious diseases like Ebola is a major public health concern. A better understanding of emerging viruses and effective new antiviral drugs are both urgently needed.
SOUNDBITE(English): WILLIAN?FISCHER, Case Management Coordinator, WHO
"I also think the important thing is that we are actually improving access to the same care regardless where you are. Whether you are in a research-rich area or resource-limited area. And for me this equal access to care is a critical issue."
Treatments are administered under a framework known as the Monitored Emergency Use of Unregistered and Investigational Interventions.
Although the number of Ebola cases has fallen in the last few weeks, multiple outbreaks of the Ebola virus infection and the likelihood of future exposure highlight the need for pre and post exposure treatments.
Meanwhile, parallel efforts are underway to establish clinical trials for the treatments as soon as possible.